Gazdar A F, Carney D N, Minna J D
Yale J Biol Med. 1981 May-Jun;54(3):187-93.
(1) serially heterotransplanted tumors in athymic nude mice; (2) continuous, clonable cell cultures; and (3) direct clonogenic assays for tumor specimens. These systems have their own individual advantages, applications, and limitations, but these are interrelated and complementary. The study of these systems has greatly aided our understanding of the biology of SCCL, and its relationship to other lung cancers and the APUD cell system. In addition, new markers for SCCL have been identified, such as a creatine kinase and its BB isoenzyme (CK-BB). These cellular markers may have clinical applications, as serum levels of CK-BB are an indicator of tumor burden. Assays for clonogenic tumor cells may permit selection of optimal drug combinations for the treatment of individual tumors. Variant cultures having the morphology of SCCL, but lacking some or all of the other features, have been identified. While our systems have been used primarily for biological studies, they have clinical applications for both diagnostic and therapeutic purposes.
我们已经开发出三种用于研究小细胞未分化肺癌(SCCL)的实验系统:(1)无胸腺裸鼠体内的系列异种移植肿瘤;(2)连续的、可克隆的细胞培养物;以及(3)肿瘤标本的直接克隆形成测定。这些系统各有其独特的优势、应用和局限性,但它们相互关联且相辅相成。对这些系统的研究极大地帮助了我们对小细胞未分化肺癌生物学特性的理解,以及它与其他肺癌和APUD细胞系统的关系。此外,已经鉴定出小细胞未分化肺癌的新标志物,如肌酸激酶及其BB同工酶(CK - BB)。这些细胞标志物可能具有临床应用价值,因为CK - BB的血清水平是肿瘤负荷的一个指标。对克隆形成性肿瘤细胞的测定可能有助于为个体肿瘤的治疗选择最佳药物组合。已经鉴定出具有小细胞未分化肺癌形态但缺乏某些或所有其他特征的变异培养物。虽然我们的系统主要用于生物学研究,但它们在诊断和治疗方面都有临床应用。